Trial Details
COMPLETEDBasic Information
| Clinical ID | c1424 |
|---|---|
| Identifier | NCT00209300 |
| Trial Title | Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Pentasa |
Participant Information
| Sponsor | Ferring Pharmaceuticals |
|---|---|
| City | Bruxelles |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-05-05 |
|---|---|
| Primary Completion Date | 2025-05-07 |
| Completion Date | 2025-06-07 |